Portfolio company
Orna Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops engineered circular RNA therapies and delivery systems to treat patients with cancer, autoimmune conditions, and genetic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Typewriter Therapeutics
The company develops RNA-based genetic medicines for patients with cancer, autoimmune conditions and rare genetic diseases.
Shape Therapeutics
The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.
CircNova
This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.
Capstan Therapeutics
Capstan Therapeutics develops in vivo RNA-based therapies for patients with autoimmune diseases and cancers using targeted lipid nanoparticle technology.
Noara Therapeutics
This company engineers stable and immunosilent ribonucleic acid therapies using machine intelligence to treat patients with chronic and complex diseases.
Kerna
This company develops an artificial intelligence platform to design and deliver messenger ribonucleic acid medicines for patients with previously untreatable conditions.
Averna Therapeutics
This biotechnology company develops genomic medicines using RNA-based technology to insert therapeutic genes into safe genomic locations for patients with various diseases.
Synthetic biology-powered mRNA therapeutics
The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.
